SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending following a record-setting quarterly earnings report that significantly surpassed revenue expectations and raised future guidance, triggering intense speculation about a potential short squeeze. Investors are aggressively debating the stock's future, weighing the company's strong fundamentals and AI sector growth against the heavy short interest and persistent volatility driven by institutional trading patterns.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending after reporting record quarterly revenue that significantly exceeded analyst expectations, driven by strong Amtagvi demand and improved manufacturing margins. The community is actively discussing the company's upward trajectory, potential analyst upgrades, and the prospect of a short squeeze as the business reaches a fundamental inflection point.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is currently the focus of intense community debate due to unverified social media rumors regarding a potential new short position by Michael Burry, which has triggered volatility and triggered high-volume trading activity. Despite the negative sentiment and bearish pressure, a large portion of the investor community remains focused on upcoming earnings, dismissing the rumors as a shake-out attempt while maintaining long-term bullish outlooks on the company's AI infrastructure and hyperscaler partnerships.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently facing intense bearish pressure and volatility as traders brace for earnings, with community sentiment deeply polarized between those calling for a capitulation-driven buying opportunity and those viewing the stock as a long-term underperformer. Market participants are fixated on potential catalysts like AI-driven ad integration and management's response to competitive pressures, while the stock continues to struggle with significant short interest and underperformance relative to the broader sector.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing extreme volatility and heavy selling pressure as investors react to a significant earnings miss characterized by a decline in core brand sales and margin compression. While some in the community view the current price as an oversold buying opportunity, others are expressing deep frustration with management and questioning the long-term growth narrative.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares experienced a sharp pullback after reporting a slight revenue miss and softer-than-expected guidance, sparking intense debate among investors over whether the sell-off is an overreaction to minor quarterly fluctuations. While some market participants are taking advantage of the dip to accumulate shares due to strong underlying profitability and recent legal clarity, others remain cautious about potential deceleration in the company's long-term growth trajectory.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently navigating a quiet period as investors await potential updates following recent earnings, with community sentiment primarily focused on whether ongoing MTA collaborations will convert into tangible licensing deals or commercial partnerships. While some investors remain optimistic about the long-term utility of the Matrix-M platform, others are expressing mounting frustration over management's lack of communication regarding the proprietary COVID-19-Influenza Combination (CIC) program and a lack of significant new catalysts.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is trending due to heightened investor sensitivity surrounding its high valuation and recent volatility, compounded by concerns over insider selling and broad weakness in the software sector. Community members are actively debating the company's long-term growth as a platform leader versus its current margin pressure, with many participants expressing frustration over the stock's significant pullbacks from recent highs.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending as the stock breaks through significant multi-year resistance, driven by strong quarterly earnings, upward guidance, and positive institutional sentiment following insider purchasing. Investors are actively debating whether this momentum can sustain a run toward the $40 level, with many viewing the current price action as a long-awaited fundamental re-rating for the health-tech platform.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing high market volatility and intense social media discussion as traders react to a mix of strong store expansion and revenue growth against concerns over earnings margins and valuation. Community sentiment remains polarized, with bulls highlighting the company's rapid footprint growth and loyal customer following, while bears caution against elevated price-to-earnings multiples and the impact of broader consumer spending headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SpaceX ($SPCX) stock is trading around $110 after a rough post-earnings sell-off. At what price would you start buying?

SpaceX ($SPCX) shares have fallen sharply post-earnings, now trading around $110 and well off their $225 high. At what price would you start buying $SPCX? Vote and explain your reasoning in the comments.

Shawn P. Ives, CPOI,CSS,CPO

Nicholas Odom

StockTwits Web

Stocktwits

SpaceX

) stock is trading around $110 after a rough post-earnings sell-off. At what price would you start buying?

Stocktwits Polls

Gmoney305

StockTwits for iOS

HedgeWIKI

@StocktwitsPolls I bought 4660 shares of FOCPX so I have my exposure there. Probably won&#39;t be buying for a year or so.

 I bought 4660 shares of FOCPX so I have my exposure there. Probably won't be buying for a year or so.